Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

2,999 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Active, Not Recruiting

Oxford Pre-cancerous Lymphoproliferative Disorders Study

NCT04023747

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
  • Russells Hall Hospital Dudley, United Kingdom
  • James Paget Hospital Great Yarmouth, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

NCT04782687

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Maryland Oncology Hematology, P.A. Columbia, Maryland, United States
  • New York Oncology Hematology, P.C. Albany, New York, United States
View Trial Details
Active, Not Recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

NCT04096066

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AO "SS. Antonio e Biagio" Alessandria, Italy
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari Bari, Italy
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

NCT04786028

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Nova Scotia Health - QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Hamilton Health Sciences Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital General Campus Ottawa, Ontario, Canada
View Trial Details
Active, Not Recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

NCT02315716

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Queen's Hospital Romford, Essex, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • NHS Lanarkshire Bothwell, United Kingdom
View all 20 locations
View Trial Details
Active, Not Recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University of Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Sussex County Hospital Brighton, United Kingdom
View all 21 locations
View Trial Details

Related conditions